• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical application and technical considerations of T & T(*) mapping in cardiac, liver, and renal imaging.T&T(*)映射在心脏、肝脏和肾脏成像中的临床应用及技术考量
Br J Radiol. 2018 Dec;91(1092):20170825. doi: 10.1259/bjr.20170825. Epub 2018 Jul 23.
2
T1 and T2 Mapping in Cardiology: "Mapping the Obscure Object of Desire".心脏病学中的T1和T2映射:“描绘难以捉摸的心仪对象”
Cardiology. 2017;138(4):207-217. doi: 10.1159/000478901. Epub 2017 Aug 17.
3
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).临床推荐意见:心血管磁共振 T1、T2、T2* 和细胞外容积mapping:心血管磁共振学会(SCMR)的共识声明,得到欧洲心血管影像协会(EACVI)的认可。
J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75. doi: 10.1186/s12968-017-0389-8.
4
Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era.多参数或实用定量肝脏磁共振成像:迈向毫秒、脂肪分数、千帕斯卡和功能时代。
Expert Rev Gastroenterol Hepatol. 2017 Feb;11(2):167-182. doi: 10.1080/17474124.2017.1271710. Epub 2016 Dec 21.
5
Cardiac Magnetic Resonance Fingerprinting: Technical Developments and Initial Clinical Validation.心脏磁共振指纹技术:技术发展与初步临床验证。
Curr Cardiol Rep. 2019 Jul 27;21(9):91. doi: 10.1007/s11886-019-1181-1.
6
Myocardial T1 and T2 Mapping: Techniques and Clinical Applications.心肌T1和T2成像:技术与临床应用
Korean J Radiol. 2017 Jan-Feb;18(1):113-131. doi: 10.3348/kjr.2017.18.1.113. Epub 2017 Jan 5.
7
Cardiac Magnetic Resonance T1-Mapping of the Myocardium: Technical Background and Clinical Relevance.心肌磁共振 T1 mapping:技术背景与临床相关性。
J Thorac Imaging. 2018 Mar;33(2):71-80. doi: 10.1097/RTI.0000000000000270.
8
Cardiac T mapping: Techniques and applications.心脏T波映射:技术与应用
J Magn Reson Imaging. 2020 May;51(5):1336-1356. doi: 10.1002/jmri.26866. Epub 2019 Jul 23.
9
Mapping the future of cardiac MR imaging: case-based review of T1 and T2 mapping techniques.描绘心脏磁共振成像的未来:基于病例的T1和T2映射技术综述
Radiographics. 2014 Oct;34(6):1594-611. doi: 10.1148/rg.346140030.
10
T1, T2 Mapping and Extracellular Volume Fraction (ECV): Application, Value and Further Perspectives in Myocardial Inflammation and Cardiomyopathies.T1、T2 映射与细胞外容积分数(ECV):在心肌炎症和心肌病中的应用、价值及进一步展望
Rofo. 2015 Sep;187(9):760-70. doi: 10.1055/s-0034-1399546. Epub 2015 Jun 22.

引用本文的文献

1
Multiparametric magnetic resonance imaging for radiotherapy response evaluation in high-risk soft tissue sarcoma: A pilot study.多参数磁共振成像用于高危软组织肉瘤放疗反应评估的一项初步研究。
Phys Imaging Radiat Oncol. 2025 Jul 25;35:100818. doi: 10.1016/j.phro.2025.100818. eCollection 2025 Jul.
2
Evaluation of multiparametric MRI and clinical indicators for renal fibrosis in chronic kidney disease.慢性肾脏病肾纤维化的多参数磁共振成像与临床指标评估
Quant Imaging Med Surg. 2025 Jul 1;15(7):6200-6216. doi: 10.21037/qims-2024-2532. Epub 2025 Jun 25.
3
Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma.磁共振成像(MRI)上脾脏T2信号强度降低与多发性骨髓瘤的疾病负担相关。
Eur Radiol. 2025 Jun;35(6):3576-3586. doi: 10.1007/s00330-024-11191-8. Epub 2024 Nov 27.
4
Feasibility and Reproducibility of T2 Mapping Compared with Diffusion-Weighted Imaging in Solid Renal Masses.T2 映射与扩散加权成像在实性肾肿块中的可行性及可重复性比较
Bioengineering (Basel). 2024 Sep 7;11(9):901. doi: 10.3390/bioengineering11090901.
5
Imaging of the Liver and Pancreas: The Added Value of MRI.肝脏和胰腺的影像学检查:磁共振成像的附加价值
Diagnostics (Basel). 2024 Mar 26;14(7):693. doi: 10.3390/diagnostics14070693.
6
Assessment of rhabdomyolysis-induced acute kidney injury with chemical exchange saturation transfer magnetic resonance imaging.利用化学交换饱和转移磁共振成像评估横纹肌溶解症所致急性肾损伤
Quant Imaging Med Surg. 2023 Dec 1;13(12):8336-8349. doi: 10.21037/qims-23-699. Epub 2023 Oct 19.
7
Personalized biomechanical insights in atrial fibrillation: opportunities & challenges.心房颤动的个性化生物力学见解:机遇与挑战。
Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(11):817-837. doi: 10.1080/14779072.2023.2273896. Epub 2023 Dec 10.
8
Parametric MRI Detects Aristolochic Acid Induced Acute Kidney Injury.参数 MRI 检测马兜铃酸诱导的急性肾损伤。
Tomography. 2022 Dec 10;8(6):2902-2914. doi: 10.3390/tomography8060243.
9
The Effects of Placental Mesenchymal Stem Cells Labeled With Ultrasmall Superparamagnetic Iron Oxides on the Growth of Colorectal Cancer Cells.超顺磁氧化铁标记胎盘间充质干细胞对结直肠癌细胞生长的影响。
J Comput Assist Tomogr. 2022;46(6):854-861. doi: 10.1097/RCT.0000000000001362. Epub 2022 Aug 23.
10
Liver T1 relaxation time of the 'normal liver' in healthy Asians: measurement with MOLLI and B-corrected VFA methods at 3T.健康亚洲人“正常肝脏”的 T1 弛豫时间:在 3T 下使用 MOLLI 和 B 校正 VFA 方法进行测量。
Br J Radiol. 2022 May 1;95(1133):20211008. doi: 10.1259/bjr.20211008. Epub 2022 Mar 24.

本文引用的文献

1
Reproducibility of native T mapping for renal tissue characterization at 3T.在 3T 下进行肾脏组织特征描述的本征 T 映射的可重复性。
J Magn Reson Imaging. 2019 Feb;49(2):588-596. doi: 10.1002/jmri.26207. Epub 2018 Sep 1.
2
Native T1 and Extracellular Volume in Transthyretin Amyloidosis.转甲状腺素蛋白淀粉样变性中的固有 T1 值和细胞外容积。
JACC Cardiovasc Imaging. 2019 May;12(5):810-819. doi: 10.1016/j.jcmg.2018.02.006. Epub 2018 Mar 14.
3
The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure.使用心血管磁共振进行组织表征在心力衰竭中的预后作用。
Card Fail Rev. 2017 Nov;3(2):86-96. doi: 10.15420/cfr.2017:19:1.
4
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).临床推荐意见:心血管磁共振 T1、T2、T2* 和细胞外容积mapping:心血管磁共振学会(SCMR)的共识声明,得到欧洲心血管影像协会(EACVI)的认可。
J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75. doi: 10.1186/s12968-017-0389-8.
5
Quantitative liver MRI including extracellular volume fraction for non-invasive quantification of liver fibrosis: a prospective proof-of-concept study.包括细胞外容积分数的定量肝脏磁共振成像用于肝纤维化的非侵入性定量:一项前瞻性概念验证研究。
Gut. 2018 Mar;67(3):593-594. doi: 10.1136/gutjnl-2017-314561. Epub 2017 Jul 28.
6
Magnetic resonance T2 mapping and diffusion-weighted imaging for early detection of cystogenesis and response to therapy in a mouse model of polycystic kidney disease.磁共振 T2 映射和弥散加权成像在多囊肾病小鼠模型中对囊发生的早期检测和治疗反应的评估。
Kidney Int. 2017 Dec;92(6):1544-1554. doi: 10.1016/j.kint.2017.05.024. Epub 2017 Jul 26.
7
Notice of Withdrawal: No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney Disease.撤稿通知:在接受透析或严重慢性肾脏病的患者中使用钆贝葡胺后未发生肾源性系统纤维化。
Radiology. 2018 Jan;286(1):113-119. doi: 10.1148/radiol.2017170102. Epub 2017 Jul 21.
8
Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation.评估实体器官移植后 T1 mapping MRI 检查的急性肾损伤。
Eur Radiol. 2018 Jan;28(1):44-50. doi: 10.1007/s00330-017-4943-4. Epub 2017 Jul 14.
9
Acute versus Chronic Myocardial Infarction: Diagnostic Accuracy of Quantitative Native T1 and T2 Mapping versus Assessment of Edema on Standard T2-weighted Cardiovascular MR Images for Differentiation.急性与慢性心肌梗死:定量 native T1 和 T2 映射与标准 T2 加权心血管 MR 图像上水肿评估对鉴别诊断的准确性比较。
Radiology. 2017 Oct;285(1):83-91. doi: 10.1148/radiol.2017162338. Epub 2017 Jul 3.
10
Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.用于评估扩张型心肌病弥漫性心肌纤维化的 native T1 mapping 和细胞外容积 mapping。
JACC Cardiovasc Imaging. 2018 Jan;11(1):48-59. doi: 10.1016/j.jcmg.2017.04.006. Epub 2017 Jun 14.

T&T(*)映射在心脏、肝脏和肾脏成像中的临床应用及技术考量

Clinical application and technical considerations of T & T(*) mapping in cardiac, liver, and renal imaging.

作者信息

Dekkers Ilona A, Lamb Hildo J

机构信息

1 Department of Radiology, Leiden University Medical Center , Leiden , The Netherlands.

出版信息

Br J Radiol. 2018 Dec;91(1092):20170825. doi: 10.1259/bjr.20170825. Epub 2018 Jul 23.

DOI:10.1259/bjr.20170825
PMID:29975154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6319842/
Abstract

Pathological tissue alterations due to disease processes such as fibrosis, edema and infiltrative disease can be non-invasively visualized and quantified by MRI using T and T relaxation properties. Pixel-wise mapping of T and T image sequences enable direct quantification of T, T(), and extracellular volume values of the target organ of interest. Tissue characterization based on T and T() mapping is currently making the transition from a research tool to a clinical modality, as clinical usefulness has been established for several diseases such as myocarditis, amyloidosis, Anderson-Fabry and iron deposition. Other potential clinical applications besides the heart include, quantification of steatosis, cirrhosis, hepatic siderosis and renal fibrosis. Here, we provide an overview of potential clinical applications of T andT() mapping for imaging of cardiac, liver and renal disease. Furthermore, we give an overview of important technical considerations necessary for clinical implementation of quantitative parametric imaging, involving data acquisition, data analysis, quality assessment, and interpretation. In order to achieve clinical implementation of these techniques, standardization of T and T() mapping methodology and validation of impact on clinical decision making is needed.

摘要

诸如纤维化、水肿和浸润性疾病等病理过程引起的组织病理改变,可以通过磁共振成像(MRI)利用T1和T2弛豫特性进行无创可视化和量化。T1和T2图像序列的逐像素映射能够直接量化感兴趣的目标器官的T1、T2以及细胞外容积值。基于T1和T2映射的组织特征分析目前正从一种研究工具向临床模式转变,因为已经确定其对心肌炎、淀粉样变性、安德森-法布里病和铁沉积等多种疾病具有临床实用性。除心脏外的其他潜在临床应用还包括脂肪变性、肝硬化、肝铁沉积和肾纤维化的量化。在此,我们概述了T1和T2映射在心脏、肝脏和肾脏疾病成像中的潜在临床应用。此外,我们还概述了定量参数成像临床应用所需考虑的重要技术因素,包括数据采集、数据分析、质量评估和解读。为了实现这些技术的临床应用,需要对T1和T2映射方法进行标准化,并验证其对临床决策的影响。